Skip to main content

CALL 1.800.EINSTEIN ²

Clinical Trials

  • Clinical Trials

    A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
    View the study at Clinicaltrials.gov


    Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
    View the study at Clinicaltrials.gov


    Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
    View the study at Clinicaltrials.gov


    A Clinical Trial Comparing the Combination of TC Plus Bevacizumab to TC Alone and to TAC for Women With Node-Positive or High-Risk Node-Negative, HER2-Negative Breast Cancer
    View the study at Clinicaltrials.gov


    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    View the study at Clinicaltrials.gov


    A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer
    View the study at Clinicaltrials.gov


    A Randomized Phase III Trial of Weekly Paclitaxel Compared to Weekly Nanoparticle Albumin Bound NAB-Paclitaxel or Ixabepilone Combined with Bevacizumab as First-Line Therapy for Locally Recurrent or Metastatic Breast Cancer.
    View the study at Clinicaltrials.gov


    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    View the study at Clinicaltrials.gov


    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    View the study at Clinicaltrials.gov


    A Randomized, Placebo-Controlled, Double-Blind Phase 2 Study of mFOLFOX6 Chemotherapy Plus Ramucirumab (IMC-1121B) Drug Product vs. mFOLFOX6 Plus Placebo for Advanced Adenocarcinoma of the Esophagus, Gastroesophageal Junction, or Stomach.
    View the study at Clinicaltrials.gov


    A Phase III Trial of 6 vs. 12 Treatments of Adjuvant FOLFOX + Celecoxib/Placebo for Patients with Resected Stage III Colon Cancer.
    View the study at Clinicaltrials.gov


    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    View the study at Clinicaltrials.gov


    Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
    View the study at Clinicaltrials.gov


    A Study of Ramucirumab (IMC-1121B) Drug Product and Best Supportive Care (BSC) vs. Placebo and BSC as Second-Line Treatment in Patients with Hepatocellular Carcinoma Following First-Line Therapy with Sorafenib.
    View the study at Clinicaltrials.gov


    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    View the study at Clinicaltrials.gov


    Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer
    View the study at Clinicaltrials.gov


    Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer
    View the study at Clinicaltrials.gov


    A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long-term Safety and Efficacy of Darbepoetin Alfa Administered at 500 µg Once-Every-3-Weeks to a Hemoglobin Ceiling of 12.0 g/dL in Anemic Subjects With Advanced Stage Non-small Cell Lung Cancer Receiving Multi-cycle Chemotherapy.
    View the study at Clinicaltrials.gov


    A Randomized, Phase III Study of Standard dosing vs. Longer Dosing Interval of Zolendronic Acid in Metastatic Cancer.
    View the study at Clinicaltrials.gov


  • Questions? Call Us:

    1.800.346.7834

    Accreditation & Partnerships



    National Accreditation Program for Breast Centers
    American Society for Radiation Oncology
    NCCCP medium
    NCCCP Program Selection

    Related Podcasts

    Colon Cancer
    Einstein doctors Donee Patterson and Richard Greenberg describe the test and risk factors for colon cancer, the most easily detected kind of cancer.


    Breast Cancer
    Einstein doctors Lisa Jablon and Donee Patterson discuss tools for treating breast cancer, including targeted therapies for dense breasts, and when to use a mammogram, ultrasound or MRI for best detection.


    Myths Surrounding Breast Cancer
    True or False? You don’t need a mammogram if you don’t have a family history of breast cancer? False: At least 60% of breast cancers have no family history at all.


    Gynecological Cancer
    Know your body and seek help if you notice any changes in your reproductive health. Our physicians discuss symptoms and treatment options for gynecological cancer.
  • Events & Support Groups
  • Schedule an Appointment

    or Browse Names A-Z

    More Scheduling Options